Evidence map›Paper›PMID 27530161›Full record

ArticleBMC genomics2016

Microarray based gene expression analysis of Sus Scrofa duodenum exposed to zearalenone: significance to human health.

Cornelia Braicu, Roxana Cojocneanu-Petric, Ancuta Jurj, Diana Gulei, Ionelia Taranu, Alexandru Mihail Gras, Daniela Eliza Marin, Ioana Berindan-Neagoe

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. In Vitro Transcriptome Response to a Mixture ofInternational journal of molecular sciences · 2018
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cornelia BraicuResearch Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu", University of Medicine and Pharmacy, Marinescu 23 Street, No. 23, 400012, Cluj-Napoca, Romania. cornelia.braicu@umfcluj.ro.
Roxana Cojocneanu-PetricResearch Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu", University of Medicine and Pharmacy, Marinescu 23 Street, No. 23, 400012, Cluj-Napoca, Romania.
Ancuta JurjResearch Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu", University of Medicine and Pharmacy, Marinescu 23 Street, No. 23, 400012, Cluj-Napoca, Romania.
Diana GuleiMEDFUTURE -Research Center for Advanced Medicine, University of Medicine and Farmacy Iuliu-Hatieganu, Cluj-Napoca, Romania.
Ionelia TaranuLaboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov, 077015, Romania.
Alexandru Mihail GrasLaboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov, 077015, Romania.
Daniela Eliza MarinLaboratory of Animal Biology, National Institute for Research and Development for Biology and Animal Nutrition, Calea Bucuresti No. 1, Balotesti, Ilfov, 077015, Romania.
Ioana Berindan-NeagoeResearch Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Hatieganu", University of Medicine and Pharmacy, Marinescu 23 Street, No. 23, 400012, Cluj-Napoca, Romania. ioana.neagoe@umfcluj.ro.
Iuliu Hațieganu University of Medicine and Pharmacy · RONational Research Development Institute for Animal Biology and Nutrition · ROInstitute of Oncology Prof. Dr. Ion Chiricuta · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZearalenone (ZEA) is a secondary metabolite produced by Fusarium species. ZEA was proved to exert a wide range of unwanted side effects, but its mechanism of action, particularly at duodenum levels, remains unclear. In our study based on the microarray technology we assessed the alteration of gene expression pattern Sus scrofa duodenum which has been previously exposed to ZEA. Gene expression data was validated by qRT-PCR and ELISA. The gene expression data were further extrapolated the results to their human orthologues and analyzed the data in the context of human health using IPA (Ingenuity Pathways Analysis).

resultsUsing Agilent microarray technology, we found that gene expression pattern was significantly affected by ZEA exposure, considering a 2-fold expression difference as a cut-off level and a p-value < 0.05. In total, we found 1576 upregulated and 2446 downregulated transcripts. About 1084 genes (764 downregulated and 751 overexpressed) were extrapolated to their human orthologues. IPA analysis showed various altered key cellular and molecular pathways. As expected, we observed a significant alteration of immune response related genes, MAPK (mitogen activate protein kinases) pathways or Toll-Like Receptors (TLRs). What captured our attention was the modulation of pathways related to the activation of early carcinogenesis.

conclusionsOur data demonstrate that ZEA has a complex effect at duodenum level. ZEA is able to activate not only the immune response related genes, but also those relate to colorectal carcinogenesis. The effects can be more dramatic when connected with the exposure to other environmental toxic agents or co-occurrence with different microorganisms.

Indexed as

Gene Expression ProfilingTranscriptomeAnimalsCytokinesDisease Models, AnimalDuodenumEstrogens, Non-SteroidalGene Expression RegulationGene Regulatory NetworksHumansReproducibility of ResultsSus scrofaZearalenoneCytokinesEstrogens, Non-SteroidalZearalenoneDuodenumExtrapolation to humanHealthMicroarraySus scrofaZearalenone

Identifiers

PMID27530161
PMCPMC4987992
OpenAlexW2513265594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.